GRTSGritstone bio, Inc.

Nasdaq gritstonebio.com


$ 0.78 $ -0.01 (-1.76 %)    

Friday, 14-Jun-2024 15:59:57 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.782
$ 0.78
$ 0.00 x 0
$ 0.00 x 0
$ 0.74 - $ 0.79
$ 0.67 - $ 3.33
752,696
na
92.58M
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-28-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jmp-securities-reiterates-market-outperform-on-gritstone-bio-maintains-5-price-target

JMP Securities analyst Roy Buchanan reiterates Gritstone Bio (NASDAQ:GRTS) with a Market Outperform and maintains $5 price t...

 b-riley-securities-reiterates-buy-on-gritstone-bio-lowers-price-target-to-3

B. Riley Securities analyst Mayank Mamtani reiterates Gritstone Bio (NASDAQ:GRTS) with a Buy and lowers the price target fro...

 hc-wainwright--co-maintains-buy-on-gritstone-bio-lowers-price-target-to-4

HC Wainwright & Co. analyst Sean Lee maintains Gritstone Bio (NASDAQ:GRTS) with a Buy and lowers the price target from $...

 gritstone-bio-q1-2024-gaap-eps-034-misses-031-estimate-sales-1742m-beat-1104m-estimate

Gritstone Bio (NASDAQ:GRTS) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.3...

 nature-medicine-publishes-interim-results-from-gritstone-bios-phase-12-study-of-off-the-shelf-neoantigen-vaccine-platform

Paper details vaccine design optimization process of Gritstone's "off-the-shelf" or shared neoantigen vaccine pla...

 nasdaq-down-over-1-vivopower-international-shares-spike-higher

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down ...

 jmp-securities-maintains-market-outperform-on-gritstone-bio-raises-price-target-to-5

JMP Securities analyst Roy Buchanan maintains Gritstone Bio (NASDAQ:GRTS) with a Market Outperform and raises the price targ...

 why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

 crude-oil-surges-over-1-us-factory-orders-increase-in-february

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded dow...

 whats-going-on-with-small-cap-cancer-vaccine-focused-gritstone-bio-stock-on-tuesday

Preliminary data released by Gritstone bio reveals results for GRANITE, a personalized neoantigen cancer vaccine, in treating m...